Reciprocal action of interferon-γ and interleukin-4 promotes granulomatous inflammation induced by Rhodococcus aurantiacus in mice

Immunology

Volumn 88, Issue 3, 1996, Pages 394-399

  Asano, M ^a   Kohanawa, M ^a   Minagawa, T ^a   Nakane, A ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GORDONA AURANTIACA; GRANULOMA; INFLAMMATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHODOCOCCUS;

EID: 0030000966     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-660.x     Document Type: Article

References (34)

1. GOODFEROW M. (1986) Genes Rhodococcus. In: Bergey's Manual of Systematic Bacteriology, (eds P.H.A. Sneath, N.S. Mair, M.E. Sharpe and J., Holf), Vol. 2, p. 1472. The Williams & Wilkins Co., Baltimore, MD.
2. TOMIYASU I., YOSHINAGA J., KURANO S. et al. (1986) Occurrence of a novel glycolipid, 'trehalose 2.3,6′-trimycolate' in psychrophilic acid-fast Rhodococcus aurantiacus (Gordona aurantiaca). FEBS Lett 203, 239.
3. TSUKAMURA M. & KAWAKAMI K. (1982) Lung infection caused by Gordona aurantiaca (Rhodococcus aurantiacus). J Clin Microbiol 16, 604.
4. MARTIN T., HOGEN, D.J., MURPHY F., NATYSHAK I. & EWAN E.P. (1991) Rhodococcuss infection of the skin with lymphadenitis in a nonimmunocompromised girl. J Am Acad Dermatol 24, 328.
5. TSUKAMURA M., HIKOSAKA K., NISHIMURA K. & HARA S. (1988) Severe progressive subcutaneous abscesses and necrotizing tenosynovitis caused by Rhodococcuss aurantiacus. J Clin Microbiol 26, 201.
6. PRINZ G., BAN E., FEKETE S. & SZABO Z. (1985) Meningitis caused by Gordona aurantiaca (Rhodococcus aurantiacus). J Clin Microbiol 22, 472.
7. ASANO M., MINAGAWA T., OHMICHI M. & HIRAGA Y. (1991) Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis. Clin Exp Immunol 94, 92.
8. + T cells in granuloma formtion of Rhodococcus aurantiacus-infected mice. Microbiol Immunol 39, 499.
9. ASANO M., NAKANE A. & MINAGAWA T. (1993) Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice. Infect Immun 61, 2872.
10. MOSMANN T.R., CHERWINSKI H., BOND M.W., GIEDLIN M.A. & COFFMAN R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348.
11. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16, 34.
12. HEINZEL. F.P., SADICK M.D., HOLADAY B.J., COFFMAN R.L. & LOCKSLEY R.M. (1989) Reciprocal expression of interferon gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169, 59.
13. LUKACS N.W. & BOROS D.L. (1993) Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni. Clin Immunol Immunopathol 68, 57.
14. PAUL W.E. & SEDER R.A. (1994) Lymphocyte responses and cytokines. Cell 76, 241.
15. DIALYNAS D.P., QUAN Z.S., WALL K.A. et al. (1983) Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK 1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131, 2445.
16. LEDBETTER J.A. & HERZENBERG L.A. (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 47, 63.
17. + cell-depleted mice. Infect Immun 59, 3439.
18. HAVELL E.A. (1986) Purification and further characterization of an anti-mouse interferon-γ monoclonal neutralizing antibody. J Interferon Res 6, 489.
19. OHARA J. & PAUL W.E. (1985) Production of a monoclonal antibody and molecular characterization of B-cell stimulatory factor-1. Nature 315, 333.
20. NAKANE A., MINAGAWA T., KOHANAWA M. et al. (1989) Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun 57, 3331.
21. NAKANE A., NUMATA A., ASANO M., KOHANAWA M., CHEN Y. & MINAGAWA T. (1990) Evidence that endogenous gamma interferon is produced early in Listeria monocytogenes infection. Infect Immun 58, 2386.
22. CZENSKINSKY C., GUDRUM A., EKRE H., NILSSON L., KLARESKOG L. & OUCHTERLONY O. (1988) Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Imnnmol Methods 110, 29.
23. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
24. NABORS G. & FARREL J.P. (1994) Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect Immun 62, 5498.
25. SCOTT P. (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147, 3149.
26. HAAK-FRENDSCHO M., BROWN J.F., IIZAWA Y., WAGNER R.D. & CZUPRYNSKI C.J. (1992) Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 148, 3978.
27. CLERICI M. & SHEARER G.M. (1994) The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15, 575.
28. - T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180, 489.
29. H2 cytokines and help B cells. Science 260, 1802.
30. + T cell. Immunol Today 15, 107.
31. CROFT M., CARTER L., SWAIN S.L. & DUTTON R.W. (1994) Generation of polarized antigen-specific CDS effector population: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180, 1715.
32. + T cells can be primed in vitro to produce IL-4. J Immunol 148, 1652.
33. + T helper type 2 cells. J Exp Med 181, 5.
34. WEINER H.L., FRIEDMAN A., MILLER A. et al. (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12, 809.